18F-FLT
Showing 1 - 25 of >10,000
Brain Tumor Trial in Salt Lake City (Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine)
Recruiting
- Brain Tumor
- Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine
-
Salt Lake City, UtahHuntsman Cancer Institute
Oct 6, 2022
Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)
Completed
- Pancreatic Adenocarcinoma
- 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
- +3 more
-
Dallas, TexasUT Southwestern Medical Center
Oct 10, 2022
Breast Tumor, Metastatic Breast Cancer, Rb+ Breast Cancer Trial in Philadelphia ([18F]FLT, PET/CT, ribociclib)
Active, not recruiting
- Breast Neoplasm
- +2 more
- [18F]FLT
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Aug 16, 2022
Ewing Sarcoma Trial in United States (drug, diagnostic test, other)
Recruiting
- Ewing Sarcoma
- Trabectedin 1 MG [Yondelis]
- +3 more
-
Los Angeles, California
- +5 more
Aug 15, 2022
Graft Vs Host Disease Trial in Chapel Hill (Fluorothymidine (FLT))
Active, not recruiting
- Graft Vs Host Disease
- Fluorothymidine (FLT)
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Mar 21, 2022
Tumors of the CNS Trial in Boston (18F-FLT, PET Imaging)
Terminated
- Tumors of the Central Nervous System
- 18F-FLT
- PET Imaging
-
Boston, MassachusettsChildren's Hospital Boston
Oct 12, 2021
Image, Body, Cervix Cancer Trial in Singapore ([18F]FLT-PET/MRI body scan)
Recruiting
- Image, Body
- Cervix Cancer
- [18F]FLT-PET/MRI body scan
-
Singapore, SingaporeNational Cancer Centre Singapore
Apr 27, 2022
Brain Tumors Trial in Boston ([18F] FLT)
Active, not recruiting
- Brain Neoplasms
- [18F] FLT
-
Boston, MassachusettsChildren's Hospital, Boston
Aug 15, 2021
Advanced Cancers Trial in Houston (PET Scan, FLT)
Active, not recruiting
- Advanced Cancers
- PET Scan
- FLT
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 16, 2022
Neurofibromatosis, MPNST Trial run by the National Cancer Institute (NCI) (MRI, FDG-PET/CT scans, [18F]-FLT-PET/CT scans)
Completed
- Neurofibromatosis
- MPNST
- MRI, FDG-PET/CT scans
- [18F]-FLT-PET/CT scans
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Detroit (drug, device, other, procedure)
Recruiting
- Recurrent Non-Small Cell Lung Carcinoma
- +3 more
- Dexamethasone
- +3 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Malignant Tumor Trial in Salt Lake City ([F-18]fluorodeoxyglucose, [F-18]fluorothymidine, Positron Emission Tomography)
Terminated
- Malignant Neoplasm
- [F-18]fluorodeoxyglucose
- +3 more
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Sep 20, 2021
Response to Immune Checkpoint Blockade in Metastatic Melanoma
Completed
- Melanoma
- F-FDG PET/CT
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Jul 7, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Duarte (procedure, drug, other)
Recruiting
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Biospecimen Collection
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 15, 2021
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)
Recruiting
- Brain and Central Nervous System Tumors
- +8 more
- 3'-deoxy-3'-[18F]fluorothymidine
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 30, 2022
Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha
Unknown status
- Essential Thrombocythemia
- +2 more
- Diagnostic (18F-FLT PET/CT)
-
Doha, QatarNational Center for Cancer Care & Research (NCCCR)
Sep 27, 2020
Advanced Cancer Trial in Houston (FLT-PET)
Completed
- Advanced Cancer
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 3, 2022
Cancer, Brain Tumors Trial in Salt Lake City (FLT-PET Imaging)
Completed
- Cancer
- Brain Tumors
- FLT-PET Imaging
-
Salt Lake City, UtahHuntsman Cancer Institute
Sep 20, 2021
NSCLC, Starting Pemetrexed Based Therapy, Unresectable Cancer Trial in Philadelphia (Baseline 18F-thymidine (FLT) PET/CT,
Terminated
- Non-small Cell Lung Cancer
- +2 more
- Baseline 18F-thymidine (FLT) PET/CT
- +2 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
May 11, 2021
Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha
Terminated
- Essential Thrombocythemia
- +3 more
- Diagnostic (18F-FLT PET/CT)
-
Doha, QatarNational Center for Cancer Care & Research (NCCCR)
Aug 10, 2020
[18F] Flourothymidine PET/CT Imaging for Gynecologic Cancers
Completed
- Gynecologic Cancer
- [18F]Fluorothymidine (FLT) PET/CT Imaging
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 5, 2021
Brain Cancer, Glioma Trial in New York (18F-FLT PET Scan)
Completed
- Brain Cancer
- Glioma
- 18F-FLT PET Scan
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Nov 20, 2020
FLT-PET/MRI for Early Response Monitoring to Novel Cancer
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- fluorine F 18 fluorothymidine
- +2 more
-
Cleveland, OhioCase Comprehensive Cancer Center
Sep 17, 2020
Metastatic Breast Cancer Trial (18F-fluorothymidine)
Completed
- Metastatic Breast Cancer
- 18F-fluorothymidine
- (no location specified)
Jun 1, 2020